CYTK tops Q2 revenue estimates as Myqorzo gains traction, but higher launch costs and the absence of

Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call Transcript

Cytokinetics NASDAQ: CYTK reported second-quarter results marked by early commercial momentum for MY

Cytokinetics (CYTK) came out with a quarterly loss of $1.5 per share versus the Zacks Consensus Esti

Britain's medicines regulator approved Cytokinetics' drug for a rare heart condition on Thursday, wi

Authorisation from MRHA and Recommendation from NICE This announcement is intended for business and

Tema's new Healthcare AI ETF (HLTH), targets AI-powered drug discovery, diagnostics, robotics an

Cytokinetics (CYTK) is positioned to expand MYQORZO across the entire HCM continuum, not just as a l

SOUTH SAN FRANCISCO, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: C

Cytokinetics (CYTK) might move higher on growing optimism about its earnings prospects, which is ref

The mean of analysts' price targets for Cytokinetics (CYTK) points to a 30.5% upside in the stock. W

The insider liquidated 7,500 shares at a weighted average price of $82.02. The disposition represent

CYTK enters a new era after Myqorzos FDA approval, with early US uptake, European expansion and life

IWN delivered a 37.4% one-year return but carries higher fees, while ISCV offers a 0.06% expense rat

Hot Line Presentation of Primary Results from ACACIA-HCM to Elaborate on Positive Topline Results in

Entertainment leader Sphere stock continues to outperform in the current market environment, setting

Large-cap pharma is back in the deal market. AbbVie's (NASDAQ: ABBV | ABBV Price Prediction) pending

SOUTH SAN FRANCISCO, Calif., June 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: C

CYTK has gained 18.4% YTD as Myqorzo's FDA approval, early launch momentum, and expanding market opp

Cytokinetics, Incorporated (CYTK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference

Program to Provide Donations to Non-Profit Organizations Aligned with Corporate Values Deadline for

Dow Jones up 200 points, Rockwell Automation shares rise 10.8% on strong earnings and raised guidanc

A fund manager who beats 99% of his peers calls Tesla stock overvalued. Here's a look at some of

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 bil

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear

  On Wednesday, 311 stocks hit new 52-week lows.

  On Tuesday, 647 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

  On Tuesday, 386 stocks made new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

  During Wednesday's trading, 103 companies set new 52-week lows.

  Wednesday saw 59 companies set new 52-week lows.